Aligos Therapeutics (ALGS) Tax Rate (2020 - 2026)
Aligos Therapeutics' (ALGS) quarterly Tax Rate came in at 215.07% in Q2 2026, up 21625.0% on a YoY basis from N/an in Q2 2025, and up 15516.71% quarter-over-quarter from 1.4% in Q1 2026.
Powered by 
Analysis
Aligos Therapeutics (ALGS) Tax Rate (2020 - 2026) Analysis & Trends
Aligos Therapeutics (ALGS) has reported Tax Rate for 7 consecutive years, with 215.07% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate rose 21625.0% year-over-year to 215.07%; the trailing twelve-month figure through Jun 2026 stood at 2.91% (up 338.0% YoY), and the FY2025 full-year result was 21.0%, up 2125.0% from the prior year.
- Tax Rate grew to 215.07% in Q2 2026 per ALGS's latest filing, from 1.4% in the prior quarter.
- Across five years, Tax Rate topped out at 215.07% in Q2 2026 and bottomed at 4.2% in Q2 2023.
- Historically, Tax Rate has averaged 13.19% across 5 years, with a median of 0.16% in 2022.
- The sharpest annual moves came in 2025 and 2026: Tax Rate slumped 478 bps in 2025, then jumped 21625 bps in 2026.
- Over 5 years, Tax Rate stood at 0.22% in 2022, then jumped by 148 bps to 0.11% in 2023, then slumped by 131 bps to 0.03% in 2024, then soared by 81292 bps to 26.69% in 2025, then jumped by 706 bps to 215.07% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 215.07%, 1.4%, and 26.69% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.34% |
| 10 | Aligos Therapeutics | 54.92 Mn | 24.48 Mn | - | 215.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 215.07% |
| Mar 31, 2026 | -1.40% |
| Dec 31, 2025 | 26.69% |
| Sep 30, 2025 | -0.18% |
| Jun 30, 2025 | -1.18% |
| Mar 31, 2025 | 0.10% |
| Dec 31, 2024 | -0.03% |
| Sep 30, 2024 | -0.47% |
| Jun 30, 2024 | 3.60% |
| Mar 31, 2024 | -0.07% |
| Dec 31, 2023 | 0.11% |
| Sep 30, 2023 | -0.16% |
| Jun 30, 2023 | -4.20% |
| Mar 31, 2023 | -0.17% |
| Dec 31, 2022 | -0.22% |
| Sep 30, 2022 | 0.23% |
| Jun 30, 2022 | -0.24% |
| Mar 31, 2022 | -0.15% |
| Dec 31, 2021 | 0.15% |
| Sep 30, 2021 | -0.38% |